The global varicella vaccines market is set for consistent growth, with revenue expected to reach USD 3,258.6 million in 2024 and expand at a CAGR of 2.4% through 2034, ultimately reaching USD 4,115.4 ...
In honor of Women’s History Month, MPR has created a quiz to celebrate the groundbreaking contributions of women in medicine.
The global viral vectors for non-human primates market was valued at USD 145.8 Mn in 2023 and is projected to grow at a CAGR ...